Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15-Reference-Cited by-同舟云学术

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

Published:2003-02-10 Issue:3 Volume:9 Page:279-286
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Brentjens Renier J.,Latouche Jean-Baptiste,Santos Elmer,Marti Francesc,Gong Michael C.,Lyddane Clay,King Philip D.,Larson Steven,Weiss Mark,Rivière Isabelle,Sadelain Michel

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm827.pdf

Reference45 articles.

1. Collins, R.H. et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15, 433–444 (1997).

2. Riddell, S.R., Murata, M., Bryant, S. & Warren, E.H. T-cell therapy of leukemia. Cancer Control 9, 114–122 (2002).

3. Papadopoulos, E.B. et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185–1191 (1994).

4. Savoldo, B., Heslop, H.E. & Rooney, C.M. The use of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus induced lymphoma in transplant recipients. Leukemia Lymphoma 39, 455–464 (2000).

5. Melief, C.J. et al. Strategies for immunotherapy of cancer. Adv. Immunol. 75, 235–282 (2000).

Cited by 562 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Exosomes of immune cell origin and their therapeutic potential for tumors;VIEW;2024-09-02

3. Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies;Cell Stem Cell;2024-09

4. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

5. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells;Cellular and Molecular Life Sciences;2024-08-31